Page last updated: 2024-10-26

dipyridamole and Atrophy

dipyridamole has been researched along with Atrophy in 3 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kern, AB1
Drucker, CR1
Duncan, WC1
Requena, L1
FariƱa, C1
Barat, A1

Other Studies

3 other studies available for dipyridamole and Atrophy

ArticleYear
Atrophie blanche. Report of two patients treated with aspirin and dipyridamole.
    Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:6

    Topics: Aged; Aspirin; Atrophy; Dipyridamole; Female; Humans; Middle Aged; Platelet Aggregation; Skin; Vascu

1982
Antiplatelet therapy in atrophie blanche and livedo vasculitis.
    Journal of the American Academy of Dermatology, 1982, Volume: 7, Issue:3

    Topics: Adult; Aged; Aspirin; Atrophy; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Pla

1982
Degos disease in a patient with acquired immunodeficiency syndrome.
    Journal of the American Academy of Dermatology, 1998, Volume: 38, Issue:5 Pt 2

    Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male;

1998